{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:45:38Z","timestamp":1793259938478,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Domp\u00e9 Farmaceutici SpA"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ophtha.2019.08.020","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T19:27:33Z","timestamp":1566847653000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":276,"title":["Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy"],"prefix":"10.1016","volume":"127","author":[{"given":"Stephen C.","family":"Pflugfelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Massaro-Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie X.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Espandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Affeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Seedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-8723","authenticated-orcid":false,"given":"Wendy","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Mantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ophtha.2019.08.020_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcp.25623","article-title":"Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves","volume":"232","author":"Mastropasqua","year":"2017","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.ophtha.2019.08.020_bib2","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2019.08.020_bib3","series-title":"Cornea","first-page":"1101","article-title":"Neurotrophic keratitis","author":"Chang","year":"2011"},{"key":"10.1016\/j.ophtha.2019.08.020_bib4","doi-asserted-by":"crossref","first-page":"805876","DOI":"10.1155\/2015\/805876","article-title":"Congenital corneal anesthesia and neurotrophic keratitis: diagnosis and management","volume":"2015","author":"Mantelli","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.ophtha.2019.08.020_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/ICL.0000000000000133","article-title":"Etiologies, quantitative hypoesthesia, and clinical outcomes of neurotrophic keratopathy","volume":"41","author":"Hsu","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.ophtha.2019.08.020_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4103\/1673-5374.213534","article-title":"Neurotrophic factors and corneal nerve regeneration","volume":"12","author":"Sacchetti","year":"2017","journal-title":"Neural Regen Res"},{"issue":"17","key":"10.1016\/j.ophtha.2019.08.020_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","article-title":"Topical treatment with nerve growth factor for corneal neurotrophic ulcers","volume":"338","author":"Lambiase","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ophtha.2019.08.020_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2019.08.020_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40259-013-0079-5","article-title":"Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial","volume":"28","author":"Ferrari","year":"2014","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.ophtha.2019.08.020_bib10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ophtha.2018.03.004","article-title":"Phase I trial of recombinant human nerve growth factor for neurotrophic keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ophtha.2019.08.020_bib11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","article-title":"Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2019.08.020_bib12","series-title":"Current Ocular Therapy","first-page":"452","article-title":"Neuroparalytic keratitis","author":"Mackie","year":"1995"},{"key":"10.1016\/j.ophtha.2019.08.020_bib13","series-title":"Translational Pain Research: From Mouse to Man","first-page":"31","article-title":"Neurotrophic factors and nociceptor sensitization","author":"Jankowski","year":"2010"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019319505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019319505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:08:08Z","timestamp":1758982088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019319505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0161642019319505"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.020","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of OphthalmologyThis is an open access article under the CC BY-NC-ND license (<inter-ref xlink: href=http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/>http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/<\/inter-ref>).","name":"copyright","label":"Copyright"}]}}